DOSSIER · 13F-HR · Q1 2026

ACORN CAPITAL ADVISORS, LLC

$352M in tracked AUM across 22 positions as of Q1 2026.

AC
CIK 0002054410 · last filed Mar 31, 2026
Total AUM
$352M
as of Q1 2026
Holdings
22
positions
Whale Score
67
67
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

ACORN CAPITAL ADVISORS, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
TERN
TERNS PHARMACEUTICALS INC
$92M1.7M26.2%
02
CGON
CG ONCOLOGY INC
$77M1.1M21.8%
03
M96088105
UROGEN PHARMA LTD
$30M1.7M8.6%
04
PBYI
PUMA BIOTECHNOLOGY INC
$26M4.1M7.5%
05
TRVI
TREVI THERAPEUTICS INC
$26M2.1M7.3%
06
CADL
CANDEL THERAPEUTICS INC
$17M3.5M4.9%
07
BCAX
BICARA THERAPEUTICS
$13M643K3.6%
08
OKUR
ONKURE THERAPEUTICS INC
$12M2.8M3.3%
09
JBIO
JADE BIOSCEINCES INC
$11M787K3.1%
10
TARA
PROTARA THERAPEUTICS INC
$9M1.8M2.6%

Filing history

2026Q1Mar 31
$352M 19.2%
22 positionsView →
2025Q4Dec 31
$295M 49.8%
21 positionsView →
2025Q3Sep 30
$197M 28.8%
20 positionsView →
2025Q2Jun 30
$153M 91.7%
21 positionsLocked
2025Q1Mar 31
$80M 56.9%
15 positionsLocked
2024Q4Dec 31
$185M
20 positionsLocked